Analysts expect athenahealth, Inc (NASDAQ:ATHN) to report $0.07 earnings per share for the current fiscal quarter, according to Zacks. Twelve analysts have provided estimates for athenahealth’s earnings. The highest EPS estimate is $0.11 and the lowest is $0.03. athenahealth reported earnings per share of $0.06 in the same quarter last year, which would suggest a positive year-over-year growth rate of 16.7%. The business is scheduled to report its next earnings report on Thursday, July 20th.

On average, analysts expect that athenahealth will report full year earnings of $0.84 per share for the current fiscal year, with EPS estimates ranging from $0.75 to $0.89. For the next fiscal year, analysts expect that the company will report earnings of $1.09 per share, with EPS estimates ranging from $0.90 to $1.25. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side research analysts that that provide coverage for athenahealth.

athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, April 27th. The health services provider reported $0.10 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.11 by $0.01. athenahealth had a net margin of 1.94% and a return on equity of 6.41%. The firm had revenue of $285.40 million for the quarter, compared to the consensus estimate of $296.49 million. During the same period in the prior year, the business earned $0.34 EPS. The company’s quarterly revenue was up 11.4% compared to the same quarter last year.

ATHN has been the subject of a number of recent research reports. Dougherty & Co dropped their target price on athenahealth from $150.00 to $143.00 and set a “buy” rating for the company in a research report on Monday, February 6th. Oppenheimer Holdings Inc. set a $142.00 target price on athenahealth and gave the stock a “buy” rating in a research report on Saturday, February 4th. Robert W. Baird set a $155.00 target price on athenahealth and gave the stock a “buy” rating in a research report on Friday, February 3rd. KeyCorp set a $140.00 target price on athenahealth and gave the stock a “buy” rating in a research report on Monday, February 6th. Finally, Berenberg Bank initiated coverage on athenahealth in a research report on Tuesday, February 7th. They set a “buy” rating and a $143.00 target price for the company. One analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $134.00.

In other athenahealth news, SVP Bradford Kyle Armbrester sold 2,431 shares of the business’s stock in a transaction dated Thursday, May 18th. The stock was sold at an average price of $130.00, for a total value of $316,030.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jonathan Bush sold 4,000 shares of the business’s stock in a transaction dated Thursday, May 18th. The shares were sold at an average price of $125.85, for a total value of $503,400.00. Following the completion of the transaction, the chief executive officer now directly owns 319,807 shares of the company’s stock, valued at $40,247,710.95. The disclosure for this sale can be found here. Over the last three months, insiders sold 16,331 shares of company stock valued at $2,020,274. Insiders own 3.04% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. boosted its position in athenahealth by 30,642.6% in the first quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock worth $180,286,000 after buying an additional 1,594,643 shares during the last quarter. Janus Capital Management LLC boosted its position in athenahealth by 18.1% in the fourth quarter. Janus Capital Management LLC now owns 5,738,978 shares of the health services provider’s stock valued at $603,596,000 after buying an additional 878,970 shares in the last quarter. Morgan Stanley boosted its position in athenahealth by 9.7% in the first quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock valued at $508,717,000 after buying an additional 397,837 shares in the last quarter. Camber Capital Management LLC purchased a new position in athenahealth during the fourth quarter valued at $31,551,000. Finally, Arrowpoint Asset Management LLC boosted its position in athenahealth by 149.1% in the fourth quarter. Arrowpoint Asset Management LLC now owns 454,069 shares of the health services provider’s stock valued at $47,754,000 after buying an additional 271,759 shares in the last quarter.

WARNING: This report was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was illegally copied and reposted in violation of US and international trademark and copyright law. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/05/24/0-07-eps-expected-for-athenahealth-inc-athn-this-quarter.html.

Shares of athenahealth (NASDAQ:ATHN) traded up 2.27% on Wednesday, reaching $135.06. The company had a trading volume of 452,340 shares. The firm has a market cap of $5.38 billion, a P/E ratio of 265.87 and a beta of 1.77. athenahealth has a one year low of $90.11 and a one year high of $142.40. The company has a 50-day moving average price of $113.06 and a 200-day moving average price of $111.55.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

12 Month Chart for NASDAQ:ATHN

Get a free copy of the Zacks research report on athenahealth (ATHN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for athenahealth Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc and related companies with MarketBeat.com's FREE daily email newsletter.